<DOC>
	<DOCNO>NCT02935751</DOCNO>
	<brief_summary>The ADIOS study prospective , observational study evaluate one hundred thirty ( 130 ) patient non-valvular atrial fibrillation currently receive treatment apixaban indicate reduce risk stroke systemic embolism , require elective major surgical invasive procedure include study . The purpose study evaluate efficacy recommend pre-procedure washout period 48 hour .</brief_summary>
	<brief_title>Apixaban Discontinuation Prior Major Surgery</brief_title>
	<detailed_description>This study estimate proportion patient 48 hour pre-procedure apixaban discontinuation sufficient achieve minimal apixaban plasma level ( less 30 ng/mL ) prior surgery . The investigator hypothesize portion 80-95 % . All patient blood draw 48 hour prior procedure second blood draw morning procedure test apixaban plasma anti-Xa level . Patients also receive follow-up phone call 30 day collect information clinical event .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>At least 18 year age On long term anticoagulation apixaban treatment nonvalvular atrial fibrillation venous thromboembolism Undergoing elective major surgery invasive procedure Inability obtain informed consent blood sample draw Any condition preclude collection followup information Participation another clinical trial Apixaban Package Insert Recommendations Cautions Women childbearing potential ( WOCBP ) must negative serum urine pregnancy test ( minimum sensitivity 25 IU/L equivalent unit HCG ) within 24 hour prior start study drug . Women must breastfeed WOCBP must agree follow instruction method ( ) contraception duration treatment study drug apixaban plus 5 halflives study drug apixaban ( approximately 3 day ) plus 30 day ( duration ovulatory cycle ) total 33 day post treatment completion . Males sexually active WOCBP must agree follow instruction method ( ) contraception duration treatment study drug apixaban plus 5 halflives study drug ( approximately 3 day ) plus 90 day ( duration sperm turnover ) total 93 day posttreatment completion . Azoospermic male WOCBP continuously heterosexually active exempt contraceptive requirement . However WOCBP must still undergo pregnancy test describe . The safety efficacy apixaban study patient prosthetic heart valve . Therefore , use recommend patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>